NCT06482905 2026-01-06Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.Tcelltech Inc.Phase 1 Recruiting52 enrolled
NCT03423992 2021-06-15Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant GliomasXuanwu Hospital, BeijingPhase 1 Unknown100 enrolled